Tybourne Capital Management (Hk) LTD Portfolio Holdings

Tybourne Capital Management (Hk) LTD has filed its 13F form on November 06, 2025 for Q3 2025 where it was disclosed a total value porftolio of $30.9 Billion distributed in 4 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Taysha Gene Therapies, Inc. with a value of $12.1B, Forte Biosciences Inc (Fbrx Us) with a value of $11.8B, Alumis Inc (Alms Us) with a value of $5.58B, and Zentalis Pharmaceuticals, Inc. with a value of $1.45B.

Examining the 13F form we can see an decrease of $3.61B in the current position value, from $34.5B to 30.9B.

Tybourne Capital Management (Hk) LTD is based out at Hong Kong, K3

Below you can find more details about Tybourne Capital Management (Hk) LTD portfolio as well as his latest detailed transactions.